Active: J Neural Transm (Vienna) Clear all

GWAS 2016-01-28

Genome-wide association analysis to predict optimal antipsychotic dosage in schizophrenia: a pilot study.

Koga AT, Strauss J et al.

J Neural Transm (Vienna)

In recent years, several studies have investigated genetic polymorphisms of antipsychotic drug-metab...

antipsychotic drug dosage in schizophrenia or schizoaffective disorder

Participants

N/A

Studies

Details PubMed

GWAS 2011-11-11

Genome-wide association study identifies 5q21 and 9p24.1 (KDM4C) loci associated with alcohol withdrawal symptoms.

Wang KS, Liu X et al.

J Neural Transm (Vienna)

Several genome-wide association (GWA) studies of alcohol dependence (AD) and alcohol-related phenoty...

Alcohol withdrawal symptoms

Replicated

1694

Participants

N/A

Studies

Details PubMed

GWAS 2008-10-07

Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies.

Lesch KP, Timmesfeld N et al.

J Neural Transm (Vienna)

A genome-wide association (GWA) study with pooled DNA in adult attention-deficit/hyperactivity disor...

Attention deficit hyperactivity disorder

647

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

Genome-wide association analysis to predict optimal antipsychotic dosage in schizophrenia: a pilot study.

Koga AT, Strauss J et al.

J Neural Transm (Vienna)

antipsychotic drug dosage in schizophrenia or schizoaffective disorder

2016-01-28

Genome-wide association study identifies 5q21 and 9p24.1 (KDM4C) loci associated with alcohol withdrawal symptoms.

Wang KS, Liu X et al.

J Neural Transm (Vienna)

Alcohol withdrawal symptoms

2011-11-11

Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies.

Lesch KP, Timmesfeld N et al.

J Neural Transm (Vienna)

Attention deficit hyperactivity disorder

2008-10-07